Results 131 to 140 of about 4,821 (183)

Amylin Receptor 1 Mutagenesis Revealed a Potential Role of Calcitonin Serine 29 in Receptor Interaction. [PDF]

Biomedicines
Song H, Jang J, Park M, Yun J, Jin J, Lee S.   +5 more
europepmc   +1 more source

How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA. [PDF]

Nephrol Dial Transplant
Morales E, Martin WP, Bevc S, Jenssen TG, Miglinas M, Trillini M.   +5 more
europepmc   +1 more source

A glimpse into the pipeline of anti-obesity medication development: combining multiple receptor pathways. [PDF]

Front Endocrinol (Lausanne)
Park C, Kim Y, Raygani S, Grunvald E.
europepmc   +1 more source

Hormonal predictors of the lean phenotype in humans. [PDF]

Biomol Biomed
Ahmed MB, Habib AM, Badran S, Alsherawi A, Al-Mohannadi F, Elnefaily SE, Hammouda A, Glass GE, Abdalhakam I, Abou-Samra AB, Doi SA.   +10 more
europepmc   +1 more source

Editorial: The impact of GIP/GIPR on metabolic diseases: how the field is evolving. [PDF]

Front Endocrinol (Lausanne)
Habegger K, Tomas A, Chen R, Harris C, Roell W, Coskun T.   +5 more
europepmc   +1 more source

Advancements and challenges in the management of obesity using pharmacotherapy (Review). [PDF]

Exp Ther Med
Alotaibi SS, Eldrehmy EH, Albogami SM, Alkhedaide A, Dahab O.   +4 more
europepmc   +1 more source

Overview of Diabetes Medications: Traditional and New-Generation Agents and Their Off-Label Use for Weight Loss. [PDF]

J Pharm Technol
Castellana E, Budau PM, Chiappetta MR.
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists in orthopaedics. [PDF]

SICOT J
Mavrogenis AF, Altsitzioglou P, Pililis S, Anastasilakis AD, Tournis S, Makras P, Saranteas T, Lustig S.   +7 more
europepmc   +1 more source

Neuropeptide TIP39 as a pluripotent brain molecule and its potential functions in postpartum depression. [PDF]

Front Endocrinol (Lausanne)
Wang S, Liu H, Tang Q, Liao N, Liu T, Yang Z, Wei Y, Fu R.   +7 more
europepmc   +1 more source

Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue. [PDF]

J Med Chem
Fischer Munch H, Just R, Mosolff Mathiesen J, Eriksson PO, Skodborg Villadsen J, Vestergaard B, Deryabina M, Demmer O, Skarbaliene J, Hamprecht DW, Rist W, Baader-Pagler T, Grube A, Heim-Riether A, Giehm L.   +14 more
europepmc   +1 more source